(Q40883384)

24 September 2017

title

Antitumour activity of cytotoxic liposomes equipped with selectin ligand SiaLe(X), in a mouse mammary adenocarcinoma model (English)

1 reference

24 September 2017

0 references

1 reference

Vodovozova EL

1

1 reference

24 September 2017

Moiseeva EV

2

1 reference

24 September 2017

Grechko GK

3

1 reference

24 September 2017

Gayenko GP

4

1 reference

24 September 2017

Nifant'ev NE

5

1 reference

24 September 2017

Bovin NV

6

1 reference

24 September 2017

Molotkovsky JG

7

1 reference

24 September 2017

publication date

1 May 2000

1 reference

European Journal of Cancer

24 September 2017

published in

1 reference

24 September 2017

volume

36

1 reference

24 September 2017

issue

7

1 reference

24 September 2017

page(s)

942-949

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

24 September 2017

1 reference

7 January 2021

Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Sterically stabilized liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Novel applications of liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Clinical studies of liposome-encapsulated doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Recent aspects in the use of liposomes in biotechnology and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Targeting of Drugs to Solid Tumors Using Anti-Her2 Immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Lipophilic 1-beta-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Immunostimulatory activity of Milife, a novel immunomodulator of fungus origin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Superantigens and retroviral infection: insights from mouse mammary tumor virus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

Selectins: interpreters of cell-specific carbohydrate information during inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900029-0

7 January 2021

10.1016/S0959-8049(00)00029-0

Identifiers

DOI

1 reference

24 September 2017

1 reference